Koninklijke DSM (OTCMKTS:RDSMY) Receives “Buy” Rating from Citigroup

Koninklijke DSM (OTCMKTS:RDSMY)‘s stock had its “buy” rating restated by stock analysts at Citigroup in a research note issued on Friday, The Fly reports.

RDSMY has been the topic of several other reports. ING Group raised Koninklijke DSM from a “sell” rating to a “buy” rating in a research report on Wednesday, September 15th. Morgan Stanley reaffirmed an “equal weight” rating on shares of Koninklijke DSM in a research report on Wednesday, August 4th. JPMorgan Chase & Co. cut Koninklijke DSM from an “overweight” rating to a “neutral” rating in a research report on Wednesday, September 1st. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Koninklijke DSM in a research report on Thursday, September 16th. Finally, Zacks Investment Research cut Koninklijke DSM from a “hold” rating to a “sell” rating in a research report on Wednesday, September 22nd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, Koninklijke DSM has an average rating of “Hold” and an average target price of $122.00.

Koninklijke DSM stock opened at $54.24 on Friday. The company has a market capitalization of $39.36 billion, a P/E ratio of 66.15, a PEG ratio of 2.55 and a beta of 0.79. The stock’s 50 day moving average is $52.55 and its 200 day moving average is $48.83. Koninklijke DSM has a twelve month low of $39.68 and a twelve month high of $55.39.

About Koninklijke DSM

Koninklijke DSM NV engages in the manufacturing and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. It operates through the following segments: Nutrition, Materials, and Innovation Center. The Nutrition segment comprises of the DSM Nutritional Products and DSM Food Specialties business groups.

Featured Story: Stock Symbols Definition, Examples, Lookup

The Fly logo

Analyst Recommendations for Koninklijke DSM (OTCMKTS:RDSMY)

Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with MarketBeat.com's FREE daily email newsletter.